Abstract
The coordination cage of the metal center in Fe(II)–bleomycin has been proposed to consist of the secondary amines in β-aminoalanine, the pyrimidinylpropionamide and imidazole rings, and the amide nitrogen in β-hydroxyhistidine as equatorial ligands, and the primary amine in β-aminoalanine and either the carbamoyl group in mannose or a solvent molecule occupying the axial sites. With the aim of supporting or not supporting coordination of a water molecule to the metal center in Fe(II)–bleomycin, the solution structure of Fe(II)–azide–bleomycin has been derived from NMR data. The structural changes that occur in Fe(II)–bleomycin upon azide binding have been monitored by comparing the experimental results with those obtained from the calculated structures for both bleomycin adducts. The results of this investigation strongly support a model of Fe(II)–bleomycin with six endogenous ligands as the most likely structure held in solution by this metallobleomycin in the absence of DNA.
Similar content being viewed by others
References
Umezawa H (1973) Biomedicine 18:459–475
Umezawa H, Maeda K, Takeuchi T, Okami Y (1966) J Antibiot 19:200–209
Bennett JM, Reich SD (1979) Ann Inter Med 90:945–948
Carlson RW, Sikic BI, Turbow MM, Ballon SC (1983) J Clin Oncol 1:645–651
Sikic BI, Rozencweig M, Carter SK (eds) (1985) Bleomycin chemotherapy. Academic, Orlando
Einhorn LH, Donohue J (1977) Ann Inter Med 87:293–298
Sausville EA, Peisach J, Horwitz SB (1976) Biochem Biophys Res Commun 73:814–822
Hecht SM (1994) Bioconj Chem 5:513–526
Kane SA, Hecht SM (1994) Prog Nucleic Acid Res Mol Biol 49:313–352
Hecht SM (2000) J Nat Prod 63:158–168
Chen JY, Stubbe J (2005) Nat Rev Cancer 5:102–112
Claussen CA, Long EC (1999) Chem Rev 99:2797–2816
Iitaka Y, Nakamura H, Nakatani T, Muraoka Y, Fujii A, Takita T, Umezawa H (1978) J Antibiot 31:1070–1072
Masanori S, Takanori K, Minoru H, Masafumi M, Yasuyuki M (2002) J Biol Chem 277:2311–2320
Goodwin KD, Lewis MA, Long EC, Georgiadis MM (2008) Proc Natl Acad Sci USA 105:5052–5056
Lehmann TE (2002) J Biol Inorg Chem 7:305–312
Lehmann TE, Serrano ML, Que L (2000) Biochemistry 39:3886–3898
Loeb KE, Zaleski JM, Hess CD, Hecht SM, Solomon EI (1998) J Am Chem Soc 120:1249–1259
Lehmann TE, Li Y (2011) J Antibiot. doi:10.1038/ja.2011.103
Tolman WB, Shuncheng L, Bentsen JG, Lippard SJ (1991) J Am Chem Soc 113:152–164
Mandon D, Ott-Woelfel F, Fisher J, Weiss R, Bill E, Trautwein AX (1990) Inorg Chem 29:2442–2447
Holz RC, Brink JM (1994) Inorg Chem 33:4609–4610
Li Y, Lehmann T (2012) J Inog Biochem (submitted)
van Gunsteren WF, Berendsen HJ (1977) Mol Phys 34:1311–1327
Acknowledgments
This work was supported by University of Wyoming start-up funds. We thank Tina Yeh (Accelrys, San Diego, CA, USA) for her very valuable guidance during molecular dynamics calculations. Our gratitude also goes to Vladimir Alvarado (University of Wyoming, Department of Petroleum and Chemical Engineering) for reviewing this manuscript and for helpful discussions.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lehmann, T., Li, Y. Solution structure of Fe(II)–azide–bleomycin derived from NMR data: transition from Fe(II)–bleomycin to Fe(II)–azide–bleomycin as derived from NMR data and structural calculations. J Biol Inorg Chem 17, 761–771 (2012). https://doi.org/10.1007/s00775-012-0894-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-012-0894-z